{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:18:31Z","timestamp":1791310711732,"version":"4.3.1"},"reference-count":40,"publisher":"National Academy of Sciences","issue":"10","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2012,3,6]]},"abstract":"<jats:p>\n                    To gain insight into the genomic basis of diffuse large B-cell lymphoma (DLBCL), we performed massively parallel whole-exome sequencing of 55 primary tumor samples from patients with DLBCL and matched normal tissue. We identified recurrent mutations in genes that are well known to be functionally relevant in DLBCL, including\n                    <jats:italic>MYD88<\/jats:italic>\n                    ,\n                    <jats:italic>CARD11<\/jats:italic>\n                    ,\n                    <jats:italic>EZH2<\/jats:italic>\n                    , and\n                    <jats:italic>CREBBP<\/jats:italic>\n                    . We also identified somatic mutations in genes for which a functional role in DLBCL has not been previously suspected. These genes include\n                    <jats:italic>MEF2B<\/jats:italic>\n                    ,\n                    <jats:italic>MLL2<\/jats:italic>\n                    ,\n                    <jats:italic>BTG1<\/jats:italic>\n                    ,\n                    <jats:italic>GNA13<\/jats:italic>\n                    ,\n                    <jats:italic>ACTB<\/jats:italic>\n                    ,\n                    <jats:italic>P2RY8<\/jats:italic>\n                    ,\n                    <jats:italic>PCLO<\/jats:italic>\n                    , and\n                    <jats:italic>TNFRSF14<\/jats:italic>\n                    . Further, we show that\n                    <jats:italic>BCL2<\/jats:italic>\n                    mutations commonly occur in patients with\n                    <jats:italic>BCL2<\/jats:italic>\n                    \/\n                    <jats:italic>IgH<\/jats:italic>\n                    rearrangements as a result of somatic hypermutation normally occurring at the\n                    <jats:italic>IgH<\/jats:italic>\n                    locus. The\n                    <jats:italic>BCL2<\/jats:italic>\n                    point mutations are primarily synonymous, and likely caused by activation-induced cytidine deaminase\u2013mediated somatic hypermutation, as shown by comprehensive analysis of enrichment of mutations in WRCY target motifs. Those nonsynonymous mutations that are observed tend to be found outside of the functionally important BH domains of the protein, suggesting that strong negative selection against\n                    <jats:italic>BCL2<\/jats:italic>\n                    loss-of-function mutations is at play. Last, by using an algorithm designed to identify likely functionally relevant but infrequent mutations, we identify\n                    <jats:italic>KRAS<\/jats:italic>\n                    ,\n                    <jats:italic>BRAF<\/jats:italic>\n                    , and\n                    <jats:italic>NOTCH1<\/jats:italic>\n                    as likely drivers of DLBCL pathogenesis in some patients. Our data provide an unbiased view of the landscape of mutations in DLBCL, and this in turn may point toward new therapeutic strategies for the disease.\n                  <\/jats:p>","DOI":"10.1073\/pnas.1121343109","type":"journal-article","created":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T00:29:26Z","timestamp":1329524966000},"page":"3879-3884","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":880,"title":["Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing"],"prefix":"10.1073","volume":"109","author":[{"given":"Jens G.","family":"Lohr","sequence":"first","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"},{"name":"Dana\u2013Farber Cancer Institute, Boston, MA 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Stojanov","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"},{"name":"Dana\u2013Farber Cancer Institute, Boston, MA 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Auclair","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Chapuy","sequence":"additional","affiliation":[{"name":"Dana\u2013Farber Cancer Institute, Boston, MA 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Sougnez","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cruz-Gordillo","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Knoechel","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"},{"name":"Dana\u2013Farber Cancer Institute, Boston, MA 02115;"},{"name":"Children's Hospital Boston, Boston, MA 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan W.","family":"Asmann","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine, Rochester, MN 55902;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Slager","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine, Rochester, MN 55902;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne J.","family":"Novak","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine, Rochester, MN 55902;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine, Rochester, MN 55902;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Ansell","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine, Rochester, MN 55902;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Link","sequence":"additional","affiliation":[{"name":"University of Iowa College of Medicine, Iowa City, IA 52245;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zou","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Gould","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Saksena","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Stransky","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Rangel-Escare\u00f1o","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Gen\u00f3mica, 14610 Mexico DF, Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Fernandez-Lopez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Gen\u00f3mica, 14610 Mexico DF, Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Hidalgo-Miranda","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Gen\u00f3mica, 14610 Mexico DF, Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Melendez-Zajgla","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Gen\u00f3mica, 14610 Mexico DF, Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Hern\u00e1ndez-Lemus","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Gen\u00f3mica, 14610 Mexico DF, Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Schwarz-Cruz y Celis","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Gen\u00f3mica, 14610 Mexico DF, Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Imaz-Rosshandler","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Medicina Gen\u00f3mica, 14610 Mexico DF, Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinyemi I.","family":"Ojesina","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonil","family":"Jung","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra S.","family":"Pedamallu","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Lander","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"},{"name":"Harvard Medical School, Boston, MA 02115;"},{"name":"Massachusetts Institute of Technology, Cambridge, MA 02142; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Habermann","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine, Rochester, MN 55902;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine, Rochester, MN 55902;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Shipp","sequence":"additional","affiliation":[{"name":"Dana\u2013Farber Cancer Institute, Boston, MA 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Getz","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd R.","family":"Golub","sequence":"additional","affiliation":[{"name":"Eli and Edythe Broad Institute, Cambridge, MA 02412;"},{"name":"Dana\u2013Farber Cancer Institute, Boston, MA 02115;"},{"name":"Harvard Medical School, Boston, MA 02115;"},{"name":"Howard Hughes Medical Institute, Chevy Chase, MD 20815"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2012,2,17]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1182\/blood-2005-02-0687","article-title":"Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach","volume":"106","author":"Abramson JS","year":"2005","unstructured":"JS Abramson, MA Shipp, Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood 106, 1164\u20131174 (2005).","journal-title":"Blood"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas","volume":"362","author":"Lenz G","year":"2010","unstructured":"G Lenz, LM Staudt, Aggressive lymphomas. N Engl J Med 362, 1417\u20131429 (2010).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: A randomised controlled trial (RICOVER-60)","volume":"9","author":"Pfreundschuh M","year":"2008","unstructured":"M Pfreundschuh, et al., Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: A randomised controlled trial (RICOVER-60). Lancet Oncol; German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) 9, 105\u2013116 (2008).","journal-title":"Lancet Oncol"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/annonc\/mdq235","article-title":"High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma","volume":"21","author":"Glass B","year":"2010","unstructured":"B Glass, et al., High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma. Ann Oncol; German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) 21, 2255\u20132261 (2010).","journal-title":"Ann Oncol"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh AA","year":"2000","unstructured":"AA Alizadeh, et al., Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503\u2013511 (2000).","journal-title":"Nature"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti S","year":"2005","unstructured":"S Monti, et al., Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105, 1851\u20131861 (2005).","journal-title":"Blood"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz G","year":"2008","unstructured":"G Lenz, et al., Stromal gene signatures in large-B-cell lymphomas. N Engl J Med; Lymphoma\/Leukemia Molecular Profiling Project 359, 2313\u20132323 (2008).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis RE","year":"2010","unstructured":"RE Davis, et al., Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463, 88\u201392 (2010).","journal-title":"Nature"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo VN","year":"2011","unstructured":"VN Ngo, et al., Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115\u2013119 (2011).","journal-title":"Nature"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz G","year":"2008","unstructured":"G Lenz, et al., Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676\u20131679 (2008).","journal-title":"Science"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin RD","year":"2010","unstructured":"RD Morin, et al., Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42, 181\u2013185 (2010).","journal-title":"Nat Genet"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci L","year":"2011","unstructured":"L Pasqualucci, et al., Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471, 189\u2013195 (2011).","journal-title":"Nature"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente XS","year":"2011","unstructured":"XS Puente, et al., Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101\u2013105 (2011).","journal-title":"Nature"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman C","year":"2007","unstructured":"C Greenman, et al., Patterns of somatic mutation in human cancer genomes. Nature 446, 153\u2013158 (2007).","journal-title":"Nature"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman MA","year":"2011","unstructured":"MA Chapman, et al., Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467\u2013472 (2011).","journal-title":"Nature"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky N","year":"2011","unstructured":"N Stransky, et al., The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157\u20131160 (2011).","journal-title":"Science"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin RD","year":"2011","unstructured":"RD Morin, et al., Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298\u2013303 (2011).","journal-title":"Nature"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci L","year":"2011","unstructured":"L Pasqualucci, et al., Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 43, 830\u2013837 (2011).","journal-title":"Nat Genet"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a002360","article-title":"The cytoskeleton coordinates the early events of B-cell activation","volume":"3","author":"Harwood NE","year":"2011","unstructured":"NE Harwood, FD Batista, The cytoskeleton coordinates the early events of B-cell activation. Cold Spring Harb Perspect Biol 3 (2011).","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/jmg.2004.021626","article-title":"Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males","volume":"41","author":"Cantagrel V","year":"2004","unstructured":"V Cantagrel, et al., Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males. J Med Genet 41, 736\u2013742 (2004).","journal-title":"J Med Genet"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia","volume":"41","author":"Mullighan CG","year":"2009","unstructured":"CG Mullighan, et al., Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet 41, 1243\u20131246 (2009).","journal-title":"Nat Genet"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/10428190701225882","article-title":"Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening","volume":"48","author":"Fujiwara S","year":"2007","unstructured":"S Fujiwara, et al., Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening. Leuk Lymphoma 48, 978\u2013986 (2007).","journal-title":"Leuk Lymphoma"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1083\/jcb.200711167","article-title":"Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocytosis","volume":"181","author":"Leal-Ortiz S","year":"2008","unstructured":"S Leal-Ortiz, et al., Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocytosis. J Cell Biol 181, 831\u2013846 (2008).","journal-title":"J Cell Biol"},{"key":"e_1_3_4_24_2","first-page":"50497","article-title":"Piccolo, a Ca2+ sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2. Piccolo complex in cAMP-dependent exocytosis","volume":"277","author":"Fujimoto K","year":"2002","unstructured":"K Fujimoto, et al., Piccolo, a Ca2+ sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2. Piccolo complex in cAMP-dependent exocytosis. J Biol Chem 277, 50497\u201350502 (2002).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/BC.2008.037","article-title":"The histone H1 family: Specific members, specific functions?","volume":"389","author":"Izzo A","year":"2008","unstructured":"A Izzo, K Kamieniarz, R Schneider, The histone H1 family: Specific members, specific functions? Biol Chem 389, 333\u2013343 (2008).","journal-title":"Biol Chem"},{"key":"e_1_3_4_26_2","article-title":"MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing","volume":"8","author":"Andreu-Vieyra CV","year":"2010","unstructured":"CV Andreu-Vieyra, et al., MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing. PLoS Biol 8 (2010).","journal-title":"PLoS Biol"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1126\/science.1198056","article-title":"The genetic landscape of the childhood cancer medulloblastoma","volume":"331","author":"Parsons DW","year":"2011","unstructured":"DW Parsons, et al., The genetic landscape of the childhood cancer medulloblastoma. Science 331, 435\u2013439 (2011).","journal-title":"Science"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.1182\/blood-2010-12-328302","article-title":"Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23\/MLL-rearranged AML patients: Results of an international study","volume":"117","author":"Coenen EA","year":"2011","unstructured":"EA Coenen, et al., Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23\/MLL-rearranged AML patients: Results of an international study. Blood 117, 7102\u20137111 (2011).","journal-title":"Blood"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ng.646","article-title":"Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome","volume":"42","author":"Ng SB","year":"2010","unstructured":"SB Ng, et al., Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 42, 790\u2013793 (2010).","journal-title":"Nat Genet"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1038\/sj.leu.2403175","article-title":"Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity","volume":"17","author":"Costello RT","year":"2003","unstructured":"RT Costello, et al., Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity. Leukemia 17, 2500\u20132507 (2003).","journal-title":"Leukemia"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jcp.21919","article-title":"The mammalian anti-proliferative BTG\/Tob protein family","volume":"222","author":"Winkler GS","year":"2010","unstructured":"GS Winkler, The mammalian anti-proliferative BTG\/Tob protein family. J Cell Physiol 222, 66\u201372 (2010).","journal-title":"J Cell Physiol"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia","volume":"19","author":"Homminga I","year":"2011","unstructured":"I Homminga, et al., Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 19, 484\u2013497 (2011).","journal-title":"Cancer Cell"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri2217","article-title":"Germinal centres: Role in B-cell physiology and malignancy","volume":"8","author":"Klein U","year":"2008","unstructured":"U Klein, R Dalla-Favera, Germinal centres: Role in B-cell physiology and malignancy. Nat Rev Immunol 8, 22\u201333 (2008).","journal-title":"Nat Rev Immunol"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci L","year":"2001","unstructured":"L Pasqualucci, et al., Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341\u2013346 (2001).","journal-title":"Nature"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1158\/1078-0432.CCR-11-0267","article-title":"BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab","volume":"17","author":"Iqbal J","year":"2011","unstructured":"J Iqbal, et al., BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab. Clin Cancer Res 17, 7785\u20137795 (2011).","journal-title":"Clin Cancer Res"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1073\/pnas.0903854106","article-title":"BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma","volume":"106","author":"Saito M","year":"2009","unstructured":"M Saito, et al., BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci USA 106, 11294\u201311299 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc2297","article-title":"Diagnosing and exploiting cancer's addiction to blocks in apoptosis","volume":"8","author":"Letai AG","year":"2008","unstructured":"AG Letai, Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 8, 121\u2013132 (2008).","journal-title":"Nat Rev Cancer"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg JW","year":"2010","unstructured":"JW Friedberg, et al., Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood 115, 2578\u20132585 (2010).","journal-title":"Blood"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/blood-2007-07-100115","article-title":"SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma","volume":"111","author":"Chen L","year":"2008","unstructured":"L Chen, et al., SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 111, 2230\u20132237 (2008).","journal-title":"Blood"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.V79.1.229.229","article-title":"Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas","volume":"79","author":"Tanaka S","year":"1992","unstructured":"S Tanaka, DC Louie, JA Kant, JC Reed, Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas. Blood 79, 229\u2013237 (1992).","journal-title":"Blood"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1121343109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T04:35:26Z","timestamp":1654576526000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1121343109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,17]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,3,6]]}},"alternative-id":["10.1073\/pnas.1121343109"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1121343109","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,17]]},"assertion":[{"value":"2012-02-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}